Vit D lowers risk of breast cancer in early life

1 April 2007

New data published in the March edition of Cancer Epidemiology Biomarkers and Prevention suggests that vitamin D may help prevent breast cancer. A team of researchers led by Julia Knight of the Samuel Lunenfeld Research Institute Ontario, Canada, found a reduced risk of breast cancer associated with increasing sun exposure from ages 10 to 19 (p=0.0006), the use of cod liver oil and increasing milk consumption (p=0.0004), all of which are common sources of vitamin D.

In the study, women with newly-diagnosed invasive breast cancer were identified from the Ontario Cancer Registry. Those without breast cancer were identified through randomly selected residential telephone numbers. Dr Knight said: "we found strong evidence to support the hypothesis that vitamin D could help prevent breast cancer. However, our results suggest that exposure earlier in life, particularly during breast development, may be most relevant." The team found weaker evidence of a protective link for vitamin D in women with breast cancer from ages 20 to 29 and no evidence for ages 45 to 54.

" This research is great news for women looking to maintain strong and healthy bodies," said Sarah Jarvis, chairperson of the International Cod Liver Oil Foundation. "By taking just one capsule of cod liver oil a day, women can not only protect their hearts and possibly help maintain healthy supple joints, but also get a healthy dose of vitamin D and protect against breast cancer.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight